Top 10 regenxbio.com Competitors

askbio.com

AskBio's researchers have defined how genetic medicine will be commercialized in the future. Learn more about our innovative gene therapy technology and how you can collaborate with us.

adverum.com

At Adverum, we are driven to establish ocular gene therapy as a new standard of care for debilitating retinal diseases.

outlooktherapeutics.com

Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME) and branch retinal vein occlusion (BRVO).

genentech-clinicaltrials.com

Genentech Clinical Trials is an informational resource for patients, caregivers, and doctors to find clear and simple language about clinical trials and inclus...

fightingblindness.org

The Foundations's Privacy Policy

macular.org

The American Macular Degeneration Foundation (AMDF) is here to help you learn about and live with Age-related Macular Degeneration (AMD). Learn more.

bluerocktx.com

Discover the science of cell and gene therapy. BlueRock turns "What if?" into "Here's how" with innovative treatments & scalable stem cell technology.

kitepharma.com

Find the Kite authorized treatment centers (ATCs) around the globe where patients can access CAR T-cell therapy.

stemcell.ucla.edu

Take the elevator up to the 14th floor of the Factor Building at UCLA and you’ll find two things: striking views of the greater San Fernando Valley — marine layer permitting — and scientists covered head-to-toe in protective gear transforming scientific discoveries into new, innovative cell therapies.

curevac.com

The extraordinary general meeting (“EGM”) of the shareholders of CureVac N.V. will take place on Tuesday, March 28, 2023, starting from 2 p.m. Central European Summer Time.